Biotech Company Releases Images Confirming Anti-tumor Activity From Metastic Breast Cancer Treatment
BriaCell's Breakthrough: Robust Anti-Tumor Activity in Metastatic Breast Cancer Patient Confirmed.
Disclaimer: This post includes affiliate links. If you make a purchase through these affiliated links, the author/website may earn a commission.
In the realm of oncology, a groundbreaking development has been made. BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer,…